Delestrogen and Atrial fibrillation aggravated - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation aggravated is reported as a side effect among people who take Delestrogen (estradiol valerate), especially for people who are female, 60+ old, also take Actemra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Atrial fibrillation aggravated when taking Delestrogen. It is created by eHealthMe based on reports of 307 people who have side effects when taking Delestrogen from the FDA, and is updated regularly.

What is Delestrogen?

Delestrogen has active ingredients of estradiol valerate. eHealthMe is studying from 320 Delestrogen users. Check the latest studies of Delestrogen.

What is Atrial fibrillation aggravated?

Atrial fibrillation aggravated (serious fibrillation of the muscles of the atria of the heart) is found to be associated with 2,184 drugs and 1,175 conditions by eHealthMe. Check the latest studies of Atrial fibrillation aggravated.



On Jul, 19, 2026

307 people reported to have side effects when taking Delestrogen.
Among them, 30 people (9.77%) have Atrial fibrillation aggravated.

Could Delestrogen cause Atrial fibrillation aggravated?

Among these 30 people:

What is the gender of people who have Atrial fibrillation aggravated when taking Delestrogen? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Atrial fibrillation aggravated when taking Delestrogen? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Delestrogen? *

  1. Actemra: 30 people, 100.00%
  2. Lipitor: 28 people, 93.33%
  3. Xanax: 28 people, 93.33%
  4. Delatestryl: 28 people, 93.33%
  5. Tylenol: 28 people, 93.33%
  6. Synthroid: 28 people, 93.33%
  7. Effexor: 28 people, 93.33%
  8. Calcium: 22 people, 73.33%
  9. Diovan: 20 people, 66.67%
  10. Eliquis: 16 people, 53.33%

What are other side effects people have besides Atrial fibrillation aggravated? *

  1. Cardiac Failure Congestive: 30 people, 100.00%
  2. Weight Increased: 29 people, 96.67%
  3. Oral Herpes (viral infection of mouth): 29 people, 96.67%
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 29 people, 96.67%
  5. Cough: 29 people, 96.67%
  6. Diarrhea: 29 people, 96.67%
  7. Ear Congestion: 29 people, 96.67%
  8. Fatigue (feeling of tiredness): 29 people, 96.67%
  9. Fungal Infection: 29 people, 96.67%
  10. Headache (pain in head): 29 people, 96.67%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 30 people, 100.00%
  2. High Blood Cholesterol: 20 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Delestrogen and have Atrial fibrillation aggravated?

- Check whether Atrial fibrillation aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Delestrogen:

Atrial fibrillation aggravated treatments and more:

How severe was Atrial fibrillation aggravated and when was it recovered:

Expand to all the drugs that have ingredients of estradiol valerate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Delestrogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation aggravated:

Browse all the conditions that are associated with Atrial fibrillation aggravated:


How the study uses the data?

The study uses data from the FDA. It is based on estradiol valerate (the active ingredients of Delestrogen) and Delestrogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: